Journals / Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi / 2017 / Sayı: 2

Diabetes and Diabetes Associated Physiologic and Pharmacokinetic Changes

Diyabet ve Diyabete Bağlı Fizyolojik ve Farmakokinetik Değişiklikler

Pages
105–123
Publication Date
2017-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it was focused on the definition, classification, prevalence, complications, treatment of diabetes and development of experimental diabetes, and changes in the enzymes and transporters levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes which is among the top five diseases causing death, is a chronic complex metabolic disease characterized by impaired carbohydrate, fat and protein metabolism.
📊
Key Findings & Data:Diabetes is classified as Type 1, Type 2, other specific types of diabetes and gestational diabetes.
💡
Conclusion & Impact:In this review, it was focused on the definition, classification, prevalence, complications, treatment of diabetes and development of experimental diabetes, and changes in the enzymes and transporters levels.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Diyabet · oral terapi · komplikasyonlar

Abstract

Diabetes which is among the top five diseases causing death, is a chronic complex metabolic disease characterized by impaired carbohydrate, fat and protein metabolism. Diabetes is classified as Type 1, Type 2, other specific types of diabetes and gestational diabetes. Acute or chronic complications are seen in diabetes as a result of decreased insulin release and disorders in carbohydrate, fat and protein metabolism. In addition, both pharmacokinetic and pharmacodynamic properties of drugs may alter due to changes in the levels of drug metabolizing enzymes and absorptive and efflux transporters responsible for drug transport. Oral antidiabetics used in the treatment of diabetes are collected in three groups; increasing insulin secretion from pancreas, increasing insulin sensitivity, and decreasing glucose absorption. Diabetes has entered into priority research areas all over the world due to the observed increase in diabetes such reasons as increase in world population, aging, urbanization, obesity frequency and physical inactivity. In this review, it was focused on the definition, classification, prevalence, complications, treatment of diabetes and development of experimental diabetes, and changes in the enzymes and transporters levels.

Özet

Ölüme neden olan hastalıklar arasında ilk beş sırada yer alan diyabet; karbonhidrat, yağ ve protein metabolizmasında bozukluk ile karakterize olan kronik kompleks metabolik bir hastalıktır. Diyabet Tip 1, Tip 2, diyabetin diğer spesifik türleri ve gestasyonel diyabet olarak sınıflandırılmaktadır. Diyabette, insülin salınımının azalması ve karbonhidrat, yağ ve protein metabolizmasında bozukluklar sonucunda akut veya kronik komplikasyonlar görülmektedir. Ayrıca diyabette ilaç metabolize eden enzimlerin ve ilaçların taşınmasından sorumlu olan absorptif ve eksorptif taşıyıcıların düzeylerinde diyabete bağlı değişiklikler olması nedeniyle ilaçların hem farmakokinetik hem de farmakodinamik özelliklerinde değişiklikler olabilmektedir. Diyabet tedavisinde kullanılan oral antidiyabetikler; pankreastan insülin salımını artıranlar, insülin duyarlılığını artıranlar ve glikoz emilimini azaltanlar olarak üç sınıfta toplanmaktadır. Dünya nüfusunun artması, yaşlanma, kentleşme, obezite sıklığı ve fiziksel hareketsizlik gibi nedenlerden dolayı diyabette gözlenen artış nedeniyle diyabet tüm dünyada öncelikli araştırma alanlarına girmiştir. Bu derlemede diyabetin sınıflandırılması, prevelansı, komplikasyonları, tedavisi, deneysel diyabet geliştirilmesi ve diyabette enzim ve taşıyıcı seviyelerindeki değişiklikler üzerinde odaklanılmıştır.

🔖

Cite This Article

GÜLSÜN, T., ŞAHİN, S. (2017). Diabetes and Diabetes Associated Physiologic and Pharmacokinetic Changes. Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi, Sayı: 2, 105–123. https://ajindex.com/articles/762323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Landersdorfer CB, Jusko WJ: Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus. Clinical Pharmacokinetics 2008, 47(7): 417-448. Bastaki A: Diabetes mellitus and its treatment. International Journal of Diabetes and Metabolism 2005, 13(3):111. Mealey BL, Ocampo GL: Diabetes mellitus and periodontal disease. Periodontology 2000 2007, 44:127-153. Türkiye Halk Sağlığı Kurumu, 2015 April 10. Available from: http://diyabet.gov.tr/index. php?lang=tr&page=32. Society for Endocrinology BES 2014., 2015 September 5. Available from: http://www.endocrine- abstracts.org/ea/0034/SFEBES2014AbstractBook.pdf. Rosenfeld L: Insulin: discovery and controversy. Clinical Chemistry 2002, 48(12): 2270-2288.
  2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5): 1047-1053.
  3. Seclen SN, Rosas ME, Arias AJ, Huayta E, Medina CA: Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study. BMJ Open Diabetes Research & Care 2015, 3(1):1-7. IDF Diabetes Atlas, 2015 June 14. Available from: http://www.idf.org/diabetesatlas/update-2014.
  4. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E: Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environmental Health Perspectives 2006, 114(5): 641-648. Donovan D: Principles of Diabetes Mellitus. Dordrecht: London: Kluwer Academic Publishers Boston, USA, 2002.
  5. Kelestimur F, Cetin M, Paşaoğlu H, Coksevim B, Cetinkaya F, Unlühizarci K, Unal S, Köker AH: The prevalence and identification of risk factors for type 2 diabetes mellitus and impaired glucose tolerance in Kayseri, Central Anatolia, Turkey. Acta Diabetologica 1999, 36(1-2):85-91.
  6. Guariguataa L, Whitingb DR, Hambletonc I, Beagleya J, Linnenkampa U, Shawd JE: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 2014, 103(2):137-149. Fawcett D: A Text Book of Histology. Chapman&Hall, New York, USA, 1994.
  7. Moore KL, Persaud TVN, Torchia MG: The Developing Human: Clinically Oriented Embryology. Elsevier Saunders, Philidelphia, USA, 1993.
  8. Ross MH, Kaye GI, Pawlina W: Histology: A Text and Atlas: With Cell and Molecular Biology. Wolters Kluwer Health, Philidelphia, USA, 2011.
  9. Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA: Pancreatic extracts in the treatment of diabete